Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weiqun Li

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Biomedical Materials (Bristol, England)|June 17, 2026
Advances in nano-delivery of natural products for cancer therapy: Mechanisms and translational strategiesXiang Chen, Huibin Wu, Xinyu Pan, et al.
Molecular Pharmaceutics|March 26, 2025
Engineered Turmeric-Derived Nanovesicles for Ulcerative Colitis Therapy by Attenuating Oxidative Stress and Alleviating InflammationGuihong Lu, Shanming Lu, Haibing Dai, et al.
Oncotarget|August 17, 2016
HBV suppresses expression of MICA/B on hepatoma cells through up-regulation of transcription factors GATA2 and GATA3 to escape from NK cell surveillanceYun Guan, Weiqun Li, Zhaohua Hou, et al.
ACS Applied Materials & Interfaces|June 23, 2022
Engineering Metal-Organic Framework Hybrid AIEgens with Tumor-Activated Accumulation and Emission for the Image-Guided GSH Depletion ROS TherapyMing-Jie Dong, Weiqun Li, Qin Xiang, et al.
Oncogene|August 1, 2002
PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cellsYong Choi, Jie Zhang, Cristina Murga, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2017
Discovery of dual Axl/VEGF-R2 inhibitors as potential anti-angiogenic and anti-metastatic drugs for cancer chemotherapyDane Goff, Jing Zhang, Thilo Heckrodt, et al.
Biomedical Materials (Bristol, England)|February 4, 2025
The application and development prospects of extracellular vesicles in oral administrationWeiqun Li, Ming-Jie Dong, Zhaoqing Shi, et al.
Hepatology (Baltimore, Md.)|February 10, 2004
Bile acids enhance the activity of the insulin receptor and glycogen synthase in primary rodent hepatocytesSong Iy Han, Elaine Studer, Seema Gupta, et al.
Journal of Cell Science|July 20, 2007
Mechanical force modulates global gene expression and beta-catenin signaling in colon cancer cellsChristopher L Avvisato, Xiang Yang, Salim Shah, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 8, 2010
Metabolism of fostamatinib, the oral methylene phosphate prodrug of the spleen tyrosine kinase inhibitor R406 in humans: contribution of hepatic and gut bacterial processes to the overall biotransformationDavid J Sweeny, Weiqun Li, Jeffrey Clough, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Biomedical Materials (Bristol, England)|June 17, 2026
Advances in nano-delivery of natural products for cancer therapy: Mechanisms and translational strategiesXiang Chen, Huibin Wu, Xinyu Pan, et al.
Molecular Pharmaceutics|March 26, 2025
Engineered Turmeric-Derived Nanovesicles for Ulcerative Colitis Therapy by Attenuating Oxidative Stress and Alleviating InflammationGuihong Lu, Shanming Lu, Haibing Dai, et al.
Oncotarget|August 17, 2016
HBV suppresses expression of MICA/B on hepatoma cells through up-regulation of transcription factors GATA2 and GATA3 to escape from NK cell surveillanceYun Guan, Weiqun Li, Zhaohua Hou, et al.
ACS Applied Materials & Interfaces|June 23, 2022
Engineering Metal-Organic Framework Hybrid AIEgens with Tumor-Activated Accumulation and Emission for the Image-Guided GSH Depletion ROS TherapyMing-Jie Dong, Weiqun Li, Qin Xiang, et al.
Oncogene|August 1, 2002
PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cellsYong Choi, Jie Zhang, Cristina Murga, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2017
Discovery of dual Axl/VEGF-R2 inhibitors as potential anti-angiogenic and anti-metastatic drugs for cancer chemotherapyDane Goff, Jing Zhang, Thilo Heckrodt, et al.
Biomedical Materials (Bristol, England)|February 4, 2025
The application and development prospects of extracellular vesicles in oral administrationWeiqun Li, Ming-Jie Dong, Zhaoqing Shi, et al.
Hepatology (Baltimore, Md.)|February 10, 2004
Bile acids enhance the activity of the insulin receptor and glycogen synthase in primary rodent hepatocytesSong Iy Han, Elaine Studer, Seema Gupta, et al.
Journal of Cell Science|July 20, 2007
Mechanical force modulates global gene expression and beta-catenin signaling in colon cancer cellsChristopher L Avvisato, Xiang Yang, Salim Shah, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 8, 2010
Metabolism of fostamatinib, the oral methylene phosphate prodrug of the spleen tyrosine kinase inhibitor R406 in humans: contribution of hepatic and gut bacterial processes to the overall biotransformationDavid J Sweeny, Weiqun Li, Jeffrey Clough, et al.
Pageof 5